文献速递重症综合管理与镇静镇痛

25年高影响力重症医学随机对照试验中女性作者比例的变化及相关因素:泄漏的管道仍在漏水

Factors associated with women authorship over 25 years in high-impact critical care randomized controlled trials: the pipeline is still leaking.
PubMed 文献 · Crit Care · 2025-08-28
一句话结论1999至2023年高影响力重症RCT女性作者占比从18%升至32%,但女性作为第一作者(21%)和高级作者(15%)仍显著不足,欧洲、以死亡率为主要终点、通气相关及研究组背书的RCT中女性比例更低。

该meta-流行病学研究筛查了1999至2023年发表在六本最高影响力综合与重症期刊上的成人重症RCT。在1,203项RCT中,1,199项(99.7%)的全部作者性别得以确定;16,057名作者中4,335名(27%)为女性。女性作为第一作者(247/1,199 [21%],p<0.001)或高级作者(174/1,199 [15%],p<0.001)的比例显著低于其他作者位置。女性作者占比以每年0.7%的变化率([0.5%-0.9%])从1999年的18%增至2023年的32%。多变量分析显示,女性比例随发表年份(OR=1.05,95%CI [1.02-1.09],p<0.01)和样本量(每增加100例患者OR=1.007 [1.003-1.012],p=0.01)显著增加,而在欧洲RCT(OR=0.53 [0.33-0.85],p<0.01)、通气相关RCT(OR=0.50 [0.25-0.97],p=0.04)、以死亡率为主要终点的RCT(OR=0.36 [0.14-0.92],p=0.03)及有研究组背书的RCT(OR=0.36 [0.18-0.69],p<0.01)中显著降低;脓毒症RCT(OR=0.74 [0.37-1.46],p=0.39)无显著差异。作者认为这反映了「泄漏的管道」框架:女性仍被排除在最高级别重症医学研究之外。

要点

  • 1999至2023年六本高影响力期刊的1,203项成人重症RCT中,女性作者仅占27%(4,335/16,057)。
  • 女性作为第一作者的比例为21%(247/1,199),作为高级作者的比例为15%(174/1,199),均显著低于其他作者位置(p<0.001)。
  • 女性作者占比从1999年的18%升至2023年的32%,变化率为每年0.7%([0.5%-0.9%])。
  • 多变量分析中,女性比例随发表年份(OR=1.05 [1.02-1.09])和样本量(每100例患者OR=1.007 [1.003-1.012])增加而显著升高。
  • 欧洲RCT(OR=0.53 [0.33-0.85])、通气相关RCT(OR=0.50 [0.25-0.97])、以死亡率为主要终点的RCT(OR=0.36 [0.14-0.92])及有研究组背书的RCT(OR=0.36 [0.18-0.69])中女性作者比例显著降低。

适用人群与场景

  • 1999至2023年发表在六本最高影响力综合与重症期刊上的成人重症RCT。

研究设计与关键结果

  • 研究类型为meta-流行病学研究,筛查1999至2023年六本最高影响力综合与重症期刊上的成人重症RCT,共纳入1,203项RCT,其中1,199项(99.7%)全部作者性别得以确定。
  • 16,057名作者中4,335名(27%)为女性;女性作为第一作者的比例为21%(247/1,199),作为高级作者的比例为15%(174/1,199),均显著低于其他作者位置(p<0.001)。
  • 女性作者占比从1999年的18%增至2023年的32%,变化率为每年0.7%([0.5%-0.9%])。
  • 多变量分析中,女性作者比例随发表年份(OR=1.05,95%CI [1.02-1.09],p<0.01)和样本量(每增加100例患者OR=1.007 [1.003-1.012],p=0.01)显著增加。
  • 多变量分析中,女性作者比例在欧洲RCT(OR=0.53 [0.33-0.85],p<0.01)、通气相关RCT(OR=0.50 [0.25-0.97],p=0.04)、以死亡率为主要终点的RCT(OR=0.36 [0.14-0.92],p=0.03)及有研究组背书的RCT(OR=0.36 [0.18-0.69],p<0.01)中显著降低;脓毒症RCT(OR=0.74 [0.37-1.46],p=0.39)无显著差异。

证据类型、等级与局限

  • 证据类型:meta-流行病学研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管25年来女性作者比例有所上升,但女性在高影响力RCT作者中仍广泛不足,尤其作为第一作者和高级作者;这种不足在欧洲、以死亡率为主要终点的试验、通气相关试验或有研究组背书的试验中更为严重,反映了「泄漏的管道」框架:女性仍被排除在最高级别重症医学研究之外。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Studies have shown an underrepresentation of women in clinical research, but little is known about trends over time and factors associated with this underrepresentation. This study aimed to investigate the evolution and the independent factors associated with the proportion of women in the authorship of high-impact critical care randomized controlled trials (RCTs) over 25 years.

METHODS: This meta-epidemiological study screened adult critical care RCTs published between 1999 and 2023 in the six highest-impact general and critical care journals. Sex was assessed using a combination of authors' biographies, available photographs, the gender R package, and a native Chinese speaker's assistance to ensure cultural accuracy. The primary outcome was the proportion of women among the authors. Unadjusted and adjusted generalized linear mixed models were performed.

RESULTS: Of 1,203 RCTs, the sex of all authors was determined in 1,199 (99.7%). Overall, 4,335 out of 16,057 authors (27%) were women. Women were less frequently first (247/1,199 [21%], p < 0.001) or senior authors (174/1,199 [15%], p < 0.001) compared to other positions. The proportion of women among authors increased by a change rate of 0.7% per year ([0.5%-0.9%]) from 18% in 1999 to 32% in 2023. In multivariable analysis, the proportion of women increased significantly per year of publication (odds ratio [OR] = 1.05, 95% confidence interval [1.02-1.09], p < 0.01) and sample size (OR = 1.007 [1.003-1.012] per 100 patients increase, p = 0.01), and decreased significantly in European RCTs (OR = 0.53 [0.33-0.85], p < 0.01), RCTs on ventilation (OR = 0.50 [0.25-0.97], p = 0.04) but not sepsis (OR = 0.74 [0.37-1.46], p = 0.39), mortality as primary outcome (OR = 0.36 [0.14-0.92], p = 0.03), and with endorsement by a study group (OR = 0.36 [0.18-0.69], p < 0.01).

CONCLUSIONS: Although the proportion of women in authorship has risen over 25 years, women are still widely underrepresented in the authors of high-impact RCTs, especially as first and senior authors. This underrepresentation is exacerbated in Europe, in trials with mortality as primary outcome, on ventilation, or endorsed by a study group. This illustrates the "leaky pipeline" framework: women are still excluded from the highest-level of critical care research.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Pensier J, De Caumia-Baillenx C, De Caumia-Baillenx A, et al. Factors associated with women authorship over 25 years in high-impact critical care randomized controlled trials: the pipeline is still leaking. Crit Care. 2025. PMID: 40877854. doi:10.1186/s13054-025-05627-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。